Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Alimentary Pharmacology & Therapeutics|November 24, 2012
One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2W J Sandborn, J-F Colombel, G D'Haens, et al.
Journal of Crohn'S & Colitis|December 22, 2010
Maintenance therapy for ulcerative colitis has no impact on changes in the extent of ulcerative colitisN Eleftheriadis, G Lambrecht, G D'Haens, et al.
Clinical and Experimental Immunology|January 18, 2006
Involvement of 4-1BB (CD137)-4-1BBligand interaction in the modulation of CD4 T cell-mediated inflammatory colitisP Maerten, B S Kwon, C Shen, et al.
Transplantation Proceedings|December 21, 2010
Living related intestinal transplantation for Churg-Strauss syndrome: a case reportT Darius, D Monbaliu, R Aerts, et al.
The British Journal of Surgery|July 27, 2017
Short- and medium-term outcomes following primary ileocaecal resection for Crohn's disease in two specialist centresA de Buck van Overstraeten, E J Eshuis, S Vermeire, et al.
Gut|February 24, 2006
A dose escalating, placebo controlled, double blind, single dose and multidose, safety and tolerability study of fontolizumab, a humanised anti-interferon gamma antibody, in patients with moderate to severe Crohn's diseaseW Reinisch, D W Hommes, G Van Assche, et al.
Alimentary Pharmacology & Therapeutics|November 22, 2017
Long-term safety of adalimumab in clinical trials in adult patients with Crohn's disease or ulcerative colitisJ-F Colombel, W J Sandborn, W Reinisch, et al.
Alimentary Pharmacology & Therapeutics|August 28, 2009
The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodiesM Allez, S Vermeire, N Mozziconacci, et al.
Transplantation Proceedings|August 16, 2006
Selection criteria and outcome of patients referred to intestinal transplantation: an European center experienceJ Pirenne, I Hoffman, M Miserez, et al.
Clinical and Experimental Immunology|August 25, 2010
Impact of lipoteichoic acid modification on the performance of the probiotic Lactobacillus rhamnosus GG in experimental colitisI J J Claes, Sarah Lebeer, C Shen, et al.
Pageof 8